INDVIndivior Pharmaceuticals, Inc.

$35.81

Who owns INDV

287 institutions reported holding INDV for 2026Q1, together 99% of the company, more than the 253 a quarter earlier.

287

Institutions reporting a position · as of 2026Q1 · up from 253 the quarter before

Shares held by institutions
127.7M

Shares held by institutions · 99% of the company · long US equity positions only, as reported on Form 13F

Reported value
$3.89B

Reported value · at 2026-03-31 prices, not today's

Top 5 holders
39%

Top 5 holders · of the whole company, between five filers

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
12
New positions
79
Positions exited
49
Added to
90
Reduced
80
Top 10 holdersof the company
54%
Institutional ownership by quarter, 2023Q2 to 2026Q1
QuarterFilersSharesReported value
2026Q1287127.7M$3.89B
2025Q4253121.3M$4.35B
2025Q3194368.6M$2.68B
2025Q2119107.0M$1.58B
2025Q111691.3M$867M
2024Q411377.8M$975M
2024Q310273.0M$834M
2024Q29964.8M$1.22B
2024Q19467.5M$3.40B
2023Q47564.4M$1.03B
2023Q37568.1M$1.91B
2023Q25862.0M$1.86B
Largest reported holders, 2026Q1
HolderShares% of companyValue
BlackRock Inc.18.5M14%$565M
VANGUARD GROUP INC14.5M11%$443M
OAKTREE CAPITAL MANAGEMENT LP7.0M5.4%$213M
STATE STREET CORP4.9M3.8%$149M
Two Seas Capital LP4.7M3.7%$145M
MILLENNIUM MANAGEMENT LLC4.6M3.6%$140M
FULLER & THALER ASSET MANAGEMENT, INC.4.5M3.5%$138M
Madison Avenue Partners, LP4.3M3.3%$132M
CITADEL ADVISORS LLC3.6M2.8%$109M
MORGAN STANLEY3.5M2.7%$107M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…